Specific pattern of 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of Alzheimer disease: Case report

Branislava Radović ,
Branislava Radović
L. Brajkovic ,
L. Brajkovic
S. Nikolic
S. Nikolic

Published: 01.12.2018.

Volume 48, Issue 1 (2019)

pp. 39-43;

https://doi.org/10.5937/pramed1901039r

Abstract

References

1.
Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, et al. Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer’s Disease, and Other Dementias. Journal of Nuclear Medicine. 2008;49(3):390–8.
2.
Panegyres PK, Rogers JM, McCarthy M, Campbell A, Wu JS. Fluorodeoxyglucose-Positron Emission Tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study. BMC Neurology. 2009;9(1).
3.
Ishii K. PET Approaches for Diagnosis of Dementia. American Journal of Neuroradiology. 2014;35(11):2030–8.
4.
Perani D, Cerami C, Caminiti SP, Santangelo R, Coppi E, Ferrari L, et al. Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting. European Journal of Nuclear Medicine and Molecular Imaging. 2016;43(3):499–508.
5.
Herholz K. FDG PET and Differential Diagnosis of Dementia. Alzheimer Disease & Associated Disorders. 1995;9(1):6–16.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by